Technologies & Assets

#UMED-TECH-003 The subject of the invention is a pharmaceutical composition in the form of an oleogel containing a drug from the group of glucocorticosteroids and its use in the treatment of non-infected inflammatory conditions of the skin, also of allergic origin, dental and gynecological diseases responding to treatment with corticosteroids. Known in the...

#UMED-TECH-002 The invention concerns a method for in vitro diagnosis of multiple sclerosis (MS ) based on the absolute count of lymphocytes with the CD49d+CD154+ phenotype autoreactive toward myelin proteins after the exposure of Peripheral Blood Mononuclear Cells to myelin peptides in the in vitro conditions. The method is useful for the early diagnosis...

#UMED-TECH-001 The subject matter of the invention is a pharmaceutical composition for topical application containing a beta- adrenergic receptor antagonist and a corticosteroid and use thereof in the treatment of hemangiomas in children. Current clinical observations indicate that haemangiomas occur in about 10% of infants. They have a pronounced clinical course that can...

#UMED-LAB-002 The living lab methodology has been enriched with elements of value-based health care and patient-centered care approaches. It shifts its focus from merely testing new solutions to ensuring delivery of  tangible health outcomes that matter most to patients. Patients are not passive subjects within the innovation process, but directly shape the development, implementation,...

#UMED-LAB-001 A state-of-the-art research laboratory providing in vivo and in vitro studies on animal models and cell lines in compliance with international standards (GLP, ISO 17025:2018-02), supporting the development of pharmaceutical and biomedical sciences Animal Research Facility of the Faculty of Pharmacy, Medical University of Lodz, is a certified research center conducting experimental...